Related Experiment Video
Updated: Jun 7, 2025

08:49
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
Inhibitory DNA Aptamer Tools against SOCS3-gp130 Interactions
Xinna Zhang1,2, Yu Hou3,2, Weichang Chen2
1Academy of Life Sciences, Faculty of Medicine, Tianjin University, Tianjin 300072, China.
ACS Applied Materials & Interfaces
|November 21, 2024
Summary
Researchers developed aptamers, a type of chemical probe, to inhibit suppressor of cytokine signaling 3 (SOCS3). These aptamers block SOCS3 interactions, offering new tools to study the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is vital for cellular communication and requires strict regulation.
- Suppressor of cytokine signaling 3 (SOCS3) is a key negative regulator in this pathway, binding to cytokine receptors.
- Limited availability of chemical probes has hindered the study of SOCS3 regulatory mechanisms.
Purpose of the Study:
- To develop novel chemical probes for investigating SOCS3 function.
- To identify aptamers capable of inhibiting SOCS3 activity.
- To explore the therapeutic potential of aptamer-based SOCS3 inhibition.
Main Methods:
- Selection and identification of specific inhibitory aptamers targeting SOCS3.
- Experimental validation of aptamer binding to SOCS3.
- Assessment of aptamer-induced disruption of SOCS3 interaction with glycoprotein 130 (gp130).
Main Results:
- Successfully identified inhibitory aptamers that bind specifically to SOCS3.
- Demonstrated that these aptamers disrupt the interaction between SOCS3 and gp130.
- Confirmed the aptamers' effect on the regulation of normal human endometrial stromal cell survival.
Conclusions:
- Developed novel aptamers as chemical tools to study SOCS3-mediated regulation of the JAK/STAT pathway.
- These aptamers provide a means to investigate SOCS3's role in cytokine receptor signaling.
- The findings suggest potential for aptamer-based therapeutics targeting SOCS3 for various conditions.

